Case Study

Roche Diagnostics: Strategy development (B)

4 pages
April 2021
Reference: IMD-7-2176

The CEO decided to hold off on announcing anything before including everyone, all 1600 employees in Roche Diagnostics, in engaging in the strategy development process, in getting their views on where the company should play and how it should win in the future. Frank Desiere, VP Strategy and Business Development, Roche Diagnostics CPS now faced a dilemma. After all of the discussions and decisions made in 2017 based on the approach he facilitated, how was he going to engage 1600 people in developing the strategy, when the strategy had already been developed?

Learning Objective
  • Cascading strategy development to as wide an audience as possible – given that strategy development in the past has been typically performed in a small group. The participants learn how to create such a journey.
Keywords
Strategy, Inclusive Leadership, Strategy Development, Strategic Planning, Strategy Alignment
Settings
World/global, Switzerland
Roche Holding, Healthcare
2017 - 2018
Type
Field Research
Copyright
© 2021
Available Languages
English
Related material
Video
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Contact

Research Information & Knowledge Hub for additional information on IMD publications

This case study is part of a series
  • Roche Diagnostics: Strategy development (A)
  • Roche Diagnostics: Strategy development (B)
  • Roche Diagnostics: Strategy development (C)
This case study is part of a series
  • Roche Diagnostics: Strategy development (A)
  • Roche Diagnostics: Strategy development (B)
  • Roche Diagnostics: Strategy development (C)
Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics
Roche Diagnostics: Strategy development (A)
By James E. Henderson and Polina Bochukova
Case reference: IMD-7-2175 ©2021
Summary
As a new CEO, Thomas Schinicker, who took over Roche Diagnostics Centralized Point of Care Solutions (CPS) in early 2018, he faced a dilemma. HIs ...
Reference IMD-7-2175
Copyright ©2021
Copyright owner IMD Copyright
Organization Roche Holding
Industry Healthcare
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Roche Diagnostics: Strategy development (B)
By James E. Henderson and Polina Bochukova
Case reference: IMD-7-2176 ©2021
Summary
The CEO decided to hold off on announcing anything before including everyone, all 1600 employees in Roche Diagnostics, in engaging in the strategy ...
Reference IMD-7-2176
Copyright ©2021
Copyright owner IMD Copyright
Organization Roche Holding
Industry Healthcare
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications

Roche Diagnostics: Strategy development (C)
By James E. Henderson and Polina Bochukova
Case reference: IMD-7-2177 ©2021
Summary
Frank Desiere, VP Strategy and Business Development, Roche Diagnostics CPS and his team including Guido Bartalena, Head of Strategy, Roche Diagnost...
Reference IMD-7-2177
Copyright ©2021
Copyright owner IMD Copyright
Organization Roche Holding
Industry Healthcare
Available Languages English
Contact

Research Information & Knowledge Hub for additional information on IMD publications